A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. Read more about A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. Read more about Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.
Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 "Gatekeeper" F691L Mutation with PLX3397. Read more about Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 "Gatekeeper" F691L Mutation with PLX3397.
Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers. Read more about Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers.
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas. Read more about Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.
The genetics of splicing in neuroblastoma. Read more about The genetics of splicing in neuroblastoma.
Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map. Read more about Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map.
Social interactomes for enabling research communities. Read more about Social interactomes for enabling research communities.
The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. Read more about The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.
Development of siRNA payloads to target KRAS-mutant cancer. Read more about Development of siRNA payloads to target KRAS-mutant cancer.
